Cape Town-based subsea engineering firm, MMO has announced the successful completion of beta testing its inhouse-designed Uni-Life 100, a non-invasive positive pressure ventilation system.
Developed in conjunction with the technical expertise and production support of Unique Group, the system has been specifically created to aid African authorities in their efforts to provide mass treatment to patients across the continent who are displaying COVID-19-related symptoms.
With the initial production batch of 10,000 units planned, the Uni-Life 100 system provides a solution which can be mass produced as a lightweight, modular and rapidly distributed alternative to other ventilator systems.
The system uses Continuous Positive Airway Pressure (CPAP) architecture, incorporating a compact gas blending and supply system which provides a therapeutic mixture of air and enriched oxygen, adjusted to a patient’s requirements. The system includes an inflatable, transparent vinyl hood which is placed over the patient’s head.
Rodney McKechnie, managing director for MMO, said: “We are proud to have locally designed and tested the compact Uni-Life 100 positive pressure ventilating system, and we are now ready to mass produce. Through our life support and hyperbaric medical equipment, we have been committed to saving lives globally; the inhouse designed ventilation system now helps raise awareness of our regional capabilities during these incredibly challenging times. The system bolsters our efforts in supporting measures to collaborate and further develop this critical treatment system to meet current demands.
“I would like to convey my thanks to the team which has worked tirelessly to complete the timely production of the first batch of these units amid the appropriate restrictions and social distancing requirements as mandated by the South African government.”
